BRAF inhibition curtails IFN‐gamma‐inducible PD‐L1 expression and upregulates the immunoregulatory protein galectin‐1 in melanoma cells-Reference-Cited by-同舟云学术

BRAF inhibition curtails IFN‐gamma‐inducible PD‐L1 expression and upregulates the immunoregulatory protein galectin‐1 in melanoma cells

Published:2020-05-19 Issue:8 Volume:14 Page:1817-1832
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Mol Oncol

Author:

Górniak Patryk¹^ORCID,Wasylecka‐Juszczyńska Maja¹,Ługowska Iwona²³⁴^ORCID,Rutkowski Piotr²^ORCID,Polak Anna¹^ORCID,Szydłowski Maciej¹^ORCID,Juszczyński Przemysław¹^ORCID

Affiliation:

1. Department of Experimental Hematology Institute of Hematology and Transfusion Medicine Warsaw Poland

2. Department of Soft Tissue/Bone Sarcoma and Melanoma Maria Sklodowska‐Curie National Research Institute of Oncology Warsaw Poland

3. Department of Biostatistics Institute of Mother and Child Warsaw Poland

4. Early Phase Clinical Trial Unit Maria Sklodowska‐Curie National Research Institute of Oncology Warsaw Poland

Funder

Narodowe Centrum Nauki

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.12695

Reference61 articles.

1. The heat shock protein 90 inhibitor IPI-504 induces apoptosis of AKT-dependent diffuse large B-cell lymphomas

2. Signatures of mutational processes in human cancer

3. BRAFV600E Co-opts a Conserved MHC Class I Internalization Pathway to Diminish Antigen Presentation and CD8+ T-cell Recognition of Melanoma

4. Galectin-1 inhibits the viability, proliferation, and Th1 cytokine production of nonmalignant T cells in patients with leukemic cutaneous T-cell lymphoma

5. The genetics of malignant melanoma: lessons from mouse and man

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulation of Nrf2/Keap1 signaling pathway in cancer drug resistance by galectin-1: cellular and molecular implications;Cancer Drug Resistance;2024-02-29

2. Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial;Nature Communications;2024-01-02

3. RNA sequencing reveals the transcriptomic landscape and alternative splicing events induced by LGALS1 silencing in non-small cell lung cancer;Advances in Clinical and Experimental Medicine;2023-06-21

4. Designing temporal- and spatial-control multifunctional nanoformulations for synergistic photodynamic–enhanced tumour immunotherapy;Nano Today;2023-04

5. Mapping of MeLiM melanoma combining ICP-MS and MALDI-MSI methods;International Journal of Biological Macromolecules;2022-04